Meela, a platform connecting people with therapists, doubled its revenue in the previous year and secured a funding round while its founder was in the delivery room. The company is backed by prominent investors and highlights the stigma around investing in founders who are building families while scaling their businesses.
Elina Berglund, former particle physicist and Nobel laureate, founded Natural Cycles, a contraceptive app with millions of global users. The interview covers company performance, ownership transitions, IPO speculation, remote work strategies, and future goals.
Respiro Diagnostics, a UK-based startup developing non-invasive breath-based diagnostics for lung diseases, raised £1 million in pre-seed funding led by Zinc Venture Capital and SFC Capital. The technology uses exhaled breath to detect lung cancer and other respiratory conditions, offering an alternative to invasive biopsies.
The AO, a Berlin-based startup, is digitizing battlefield medicine with wearable sensors and AI to monitor casualties during evacuation. Founded by Howard Hunt, the platform aims to automate data collection for military and civilian emergency use, with partnerships in Ukraine and NATO integration plans.
French hospitals and startup Kiro launched OPTIMABIO, an AI project to improve hospital biology test prescriptions. The initiative, funded by Marseille, Lyon, and Limoges hospitals, aims to transform routine medical decisions using artificial intelligence.
Allergen Alert, a French startup, has been selected as a finalist in the Fundtruck 2025 competition and will represent France at the global Startup World Cup in San Francisco.
Rubik Hub, a Romanian startup community, partnered with BBI Cambridge to support HealthTech startups through scholarships, international events, and access to investors. Three startups received MBA scholarships, and a UK-Polish Life Sciences Summit was announced for September 2026.
CurifyLabs, a Finnish health technology company, secured €12 million in Series A funding led by Sandwater and HealthCap. The investment will support expansion into the US, supply chain development, and the advancement of its automated pharmaceutical compounding platform, which is already used by pharmacies in 21 US states and Europe.
Neko Health, a longevity-focused health company founded by Daniel Ek, has raised 265 million SEK in funding and opened a clinic in New York. The company continues to expand despite already having a substantial cash reserve.
Swiss biotech startup ALP Bio has secured €161,000 from Venture Kick to develop a platform combining human immune tissue models and AI to predict immune-related risks in biologic drug development, improving safety and success rates.